GLP-1 Receptor Agonists Crowd into Diabetes Market
As the 72nd annual scientific sessions of the American Diabetes Association (ADA) drew to a close last week, the world's leading diabetes experts were left in no doubt that the market for glucagon-like peptide-1 (GLP-1) receptor agonists is becoming highly competitive.
Sign up for Perspectives FREE e-mail newsletter.
Outside the U.S.: 1-404-262-5423
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST